Santo Therapeutics

Santo Therapeutics is established by experienced genetic scientists and biotechnological experts from University of Cambridge, University College London, etc. Technical team are excellent in the development and manufacture of novel viral vector and manufacture. With our next generation viral vector platforms, Santo Therapeutics is committed to develop in house Pipeline programs to treat rare diseases with highly unmet medical need worldwide. The current projects involves in neurodegenerative and neuro-oncological diseases. Also, we are interested in partnerships with biopharmaceutical players in other disease areas.